Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Protein Glycosylation
Proteoglycans
Glycolysis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 8, 2025

Tracking Hypoxic Signaling within Encapsulated Cell Aggregates
Published on: December 16, 2011
Cindy N Ho1, Alessandra T Ayers1, Paul Beisswenger2,3
1Diabetes Technology Society, Burlingame, CA, USA.
Advanced glycation end products (AGEs) are crucial biomarkers for predicting diabetic kidney disease and cardiovascular disease. This webinar reviewed progress in AGEs measurement and clinical application.
Area of Science:
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:05Advanced Glycation End-Products Sensitize Human Sensory-Like Neuron Cells to Capsaicin-Induced Calcium Influx
Published on: May 2, 2025
Background: